Search

Your search keyword '"Vohanka, Stanislav"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Vohanka, Stanislav" Remove constraint Author: "Vohanka, Stanislav"
28 results on '"Vohanka, Stanislav"'

Search Results

1. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

3. Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

4. Trunk muscle dysfunction in patients with myotonic dystrophy type 2 and its contribution to chronic low back pain.

6. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

7. Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

9. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

11. Additional file 1: of Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

12. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

13. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

14. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

15. Anaesthesia and orphan disease

16. 225th ENMC international workshop:: A global FSHD registry framework, 18–20 November 2016, Heemskerk, The Netherlands

17. Poster 156 Dysport ® , AbobotulinumtoxinA, Improves Disease‐Specific Quality of Life in Patients with Cervical Dystonia, as Measured by Patient‐Reported Outcomes, in a Phase III, Randomized, Double‐Blind, Placebo‐Controlled Study

19. Towards a predictive model for post-stroke delirium

20. Poststroke delirium incidence and outcomes

27. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Catalog

Books, media, physical & digital resources